BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Prostate cancer AND FANCD2, FANCD, 2177, ENSG00000144554, FLJ23826, FAD, FACD, FA4, FA-D2, FAD2, DKFZp762A223
31 results:

  • 1. The influence of Gleason score ≤ 6 histology on the outcome of high-risk localized prostate cancer after modern radiotherapy.
    Yamazaki H; Suzuki G; Masui K; Aibe N; Kimoto T; Yamada K; Okihara K; Hongo F; Okumi M; Shiraishi T; Fujihara A; Yoshida K; Nakamura S; Kato T; Hashimoto Y; Okabe H
    Sci Rep; 2024 Apr; 14(1):8011. PubMed ID: 38580670
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Synthesis and anti-cancer potential of potent peripheral MAOA inhibitors designed to limit blood:brain penetration.
    Jacobs MR; Olivero JE; Ok Choi H; Liao CP; Kashemirov BA; Katz JE; Gross ME; McKenna CE
    Bioorg Med Chem; 2023 Sep; 92():117425. PubMed ID: 37544256
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Comparison of holmium laser, bipolar and conventional monopolar transurethral resection of bladder tumour in primary non-muscle invasive bladder cancer.
    Elmekawy S; Taha DE; Nabeeh HE; Ibrahim A; Zeid AE; Abdelbaky T
    J Pak Med Assoc; 2023 Apr; 73(Suppl 4)(4):S251-S256. PubMed ID: 37482868
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. The effect of renalase-derived peptides on viability of HepG₂ and PC3 cells.
    Fedchenko VI; Morozevich GE; Medvedev AE
    Biomed Khim; 2023 Jun; 69(3):184-187. PubMed ID: 37384910
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Genomic characterization of metastatic castration-resistant prostate cancer patients undergoing PSMA radioligand therapy: A single-center experience.
    Satapathy S; Das CK; Aggarwal P; Sood A; Parihar AS; Singh SK; Mittal BR
    Prostate; 2023 Feb; 83(2):169-178. PubMed ID: 36259290
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. prostate cancer cells demonstrate unique metabolism and substrate adaptability acutely after androgen deprivation therapy.
    Filon MJ; Gillette AA; Yang B; Khemees TA; Skala MC; Jarrard DF
    Prostate; 2022 Dec; 82(16):1547-1557. PubMed ID: 35980831
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. BoxCar and shotgun proteomic analyses reveal molecular networks regulated by UBR5 in prostate cancer.
    Yan Y; Zhou B; Lee YJ; You S; Freeman MR; Yang W
    Proteomics; 2022 Feb; 22(4):e2100172. PubMed ID: 34897998
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Prognostic Factors Associated With Surviving Less Than 3 Months vs Greater Than 3 Years Specific to Spine Stereotactic Body Radiotherapy and Late Adverse Events.
    Zeng KL; Sahgal A; Tseng CL; Myrehaug S; Soliman H; Detsky J; Atenafu EG; Lee Y; Campbell M; Maralani P; Husain ZA
    Neurosurgery; 2021 Apr; 88(5):971-979. PubMed ID: 33475723
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. An Elegant Four-Helical Fold in NOX and STEAP Enzymes Facilitates Electron Transport across Biomembranes-Similar Vehicle, Different Destination.
    Oosterheert W; Reis J; Gros P; Mattevi A
    Acc Chem Res; 2020 Sep; 53(9):1969-1980. PubMed ID: 32815713
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Multiphoton FLIM imaging of NAD(P)H and fad with one excitation wavelength.
    Cao R; Wallrabe H; Periasamy A
    J Biomed Opt; 2020 Jan; 25(1):1-16. PubMed ID: 31920048
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Cryo-EM structures of human STEAP4 reveal mechanism of iron(III) reduction.
    Oosterheert W; van Bezouwen LS; Rodenburg RNP; Granneman J; Förster F; Mattevi A; Gros P
    Nat Commun; 2018 Oct; 9(1):4337. PubMed ID: 30337524
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Prevalence of DNA repair gene mutations in localized prostate cancer according to clinical and pathologic features: association of Gleason score and tumor stage.
    Marshall CH; Fu W; Wang H; Baras AS; Lotan TL; Antonarakis ES
    Prostate Cancer Prostatic Dis; 2019 Mar; 22(1):59-65. PubMed ID: 30171229
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Targeted next generation sequencing identifies functionally deleterious germline mutations in novel genes in early-onset/familial prostate cancer.
    Paulo P; Maia S; Pinto C; Pinto P; Monteiro A; Peixoto A; Teixeira MR
    PLoS Genet; 2018 Apr; 14(4):e1007355. PubMed ID: 29659569
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Segmented cell analyses to measure redox states of autofluorescent NAD(P)H, fad & Trp in cancer cells by FLIM.
    Wallrabe H; Svindrych Z; Alam SR; Siller KH; Wang T; Kashatus D; Hu S; Periasamy A
    Sci Rep; 2018 Jan; 8(1):79. PubMed ID: 29311591
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Structure-activity studies on N-Substituted tranylcypromine derivatives lead to selective inhibitors of lysine specific demethylase 1 (LSD1) and potent inducers of leukemic cell differentiation.
    Schulz-Fincke J; Hau M; Barth J; Robaa D; Willmann D; Kürner A; Haas J; Greve G; Haydn T; Fulda S; Lübbert M; Lüdeke S; Berg T; Sippl W; Schüle R; Jung M
    Eur J Med Chem; 2018 Jan; 144():52-67. PubMed ID: 29247860
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Investigation of Mitochondrial Metabolic Response to Doxorubicin in prostate cancer Cells: An NADH, fad and Tryptophan FLIM Assay.
    Alam SR; Wallrabe H; Svindrych Z; Chaudhary AK; Christopher KG; Chandra D; Periasamy A
    Sci Rep; 2017 Sep; 7(1):10451. PubMed ID: 28874842
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Six-Transmembrane Epithelial Antigen of prostate 1 (STEAP1) Has a Single b Heme and Is Capable of Reducing Metal Ion Complexes and Oxygen.
    Kim K; Mitra S; Wu G; Berka V; Song J; Yu Y; Poget S; Wang DN; Tsai AL; Zhou M
    Biochemistry; 2016 Dec; 55(48):6673-6684. PubMed ID: 27792302
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. [Function of CDK12 in Tumor initiation and progression and its clinical consequences].
    Vrábel D; Svoboda M; Navrátil J; Kohoutek J
    Klin Onkol; 2014; 27(5):340-6. PubMed ID: 25312711
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. A microfluidic coculture and multiphoton fad analysis assay provides insight into the influence of the bone microenvironment on prostate cancer cells.
    Bischel LL; Casavant BP; Young PA; Eliceiri KW; Basu HS; Beebe DJ
    Integr Biol (Camb); 2014 Jun; 6(6):627-635. PubMed ID: 24791272
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Prevalence and characteristics of moderate to severe fatigue: a multicenter study in cancer patients and survivors.
    Wang XS; Zhao F; Fisch MJ; O'Mara AM; Cella D; Mendoza TR; Cleeland CS
    Cancer; 2014 Feb; 120(3):425-32. PubMed ID: 24436136
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.